Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Sanuo Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Chongqing, China, and operates as a wholly-owned subsidiary of Chongqing Pharscin Pharmaceutical. Established in 1994, the company focuses on the research, development, and production of chemical drugs and active pharmaceutical ingredients (APIs). Its product portfolio covers several key therapeutic areas, including gastroenterology, cardiovascular disease, and respiratory health. The company is well-known for its production of aluminum magnesium carbonate, a widely used antacid, along with various generic medications for chronic conditions like hypertension and diabetes. Sanuo maintains modern, GMP-certified manufacturing facilities that support the large-scale production of solid dosage forms such as tablets and capsules. As a core component of the Pharscin Pharmaceutical group, Sanuo plays a vital role in the parent company's integrated supply chain and market expansion strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Sanuo Pharmaceutical.